MedPath

the effect of vitamin D in the treatment of chemotherapy-induced fever and neutropenia in children with malignancy

Phase 3
Completed
Conditions
Fever and neutropenia.
Registration Number
IRCT20240608062045N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

pediatric hematology and oncology department of Amirkabir Arak Hospital, aged 1 to 16 years, with fever and neutropenia due to chemotherapy, informed consent of the patient's parents for the child to participate in the study, the initial vitamin D level is lower than the normal level) by the initial vitamin D level test D is measured and values ??less than 20 ng/ml are considered as deficiency and values ??of 29 ng/ml are considered as insufficient.) Not taking vitamins arbitrarily

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.